CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $10,000 | +66.7% | 5,006 | 0.0% | 0.00% | – |
Q4 2020 | $6,000 | -33.3% | 5,006 | 0.0% | 0.00% | – |
Q3 2020 | $9,000 | -78.6% | 5,006 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $42,000 | +61.5% | 5,006 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $26,000 | +23.8% | 5,006 | +28.8% | 0.00% | 0.0% |
Q4 2019 | $21,000 | +10.5% | 3,888 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $19,000 | -29.6% | 3,888 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $27,000 | 0.0% | 3,888 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $27,000 | +17.4% | 3,888 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $23,000 | -20.7% | 3,888 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $29,000 | +45.0% | 3,888 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $20,000 | -16.7% | 3,888 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $24,000 | -14.3% | 3,888 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $28,000 | -6.7% | 3,888 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $30,000 | +25.0% | 3,888 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $24,000 | – | 3,888 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
Platform Technology Partners | 33,750 | $9,000 | 0.01% |
PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
Aries Wealth Management | 15,400 | $4,000 | 0.00% |